Implementing a Rehabilitation Program in Patients Recovering From Covid-19 Infection - Trial NCT04935437
Access comprehensive clinical trial information for NCT04935437 through Pure Global AI's free database. This phase not specified trial is sponsored by Evangelismos Hospital and is currently Recruiting. The study focuses on Rehabilitation. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Evangelismos Hospital
Timeline & Enrollment
N/A
Jan 21, 2021
Sep 01, 2021
Primary Outcome
Assessment of quality of life using SF-36 questionnaire.,Assessment of depression with Beck Depression Inventory,Assessment of cognitive dysfunction,Assessment of shortness of breath,Assessment of fatigue with Fatigue Severity Scale,Assessment of functional capacity with 6MWT.,Assessment of respiratory function with FEV1,Assessment of symptoms after COVID-19 with CAT.,Assessment of symptoms after COVID-19 with PCFSS.,Assessment of fatigue using chalder fatigue scale.,Assessment of balance.,Assessment of fatigue with FACIT fatigue Scale,Assessment of physical activity with IPAQ.,Assessment of quality of life using EQ-5D-5L questionnaire.,Assessment of respiratory function with FVC,Assessment of lung diffusion capacity.,Assessment of anxiety and depression with HADS,Assessment of Post Traumatic Stress Disorder with the Impact of Event Scale.,Assessment of functional capacity with Short Physical Performance Battery.,Assessment of functional capacity with one minute sit to stand test.,Assessment of lower extremity strength
Summary
Implementation of a supervised rehabilitation program in patients recovering from
 COVID-19-infection who suffer from limitations and symptoms due to the disease at least 1
 month after discharge from hospital. Patients who have been seriously ill and have been
 admitted to the ward with high oxygen mixtures or have been admitted to the ICU will be
 selected primarily. The program includes supervised rehabilitation sessions 2 times a week
 for 2 months. Patients will be evaluated during recruitment and at the end of the program.
 Patients who can not or do not want to attend the program will be re-evaluated in 2 months
 and constitute the control population. Investigators hypothesis is that post COVID-19
 patients who have persistent symptoms following a supervised rehabilitation program will have
 fewer symptoms after the end of the program compared to similar patients who do not attend a
 rehabilitation program.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04935437
Non-Device Trial